ContraFect Corporation (CFRXQ)
USD 0.0
(-50.0%)
USD 0.0
(-50.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2022 | -6.02 Million USD | 54.99% |
| 2021 | -13.38 Million USD | -12.68% |
| 2020 | -11.88 Million USD | 41.44% |
| 2019 | -20.28 Million USD | -143.84% |
| 2018 | -8.32 Million USD | -18.95% |
| 2017 | -6.99 Million USD | -83.74% |
| 2016 | -3.8 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 Q2 | -11.75 Million USD | -29.31% |
| 2023 Q1 | -9.09 Million USD | -50.88% |
| 2023 Q3 | -2.86 Million USD | 75.67% |
| 2022 Q1 | -6.46 Million USD | 51.73% |
| 2022 Q2 | -6.47 Million USD | -0.12% |
| 2022 Q4 | -6.02 Million USD | -257.84% |
| 2022 Q3 | -1.68 Million USD | 73.98% |
| 2021 Q3 | -16.87 Million USD | 0.0% |
| 2021 Q4 | -13.38 Million USD | 20.64% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Burzynski Research Institute, Inc. | -1310.00 USD | -459900.0% |
| Arch Therapeutics, Inc. | 5.64 Million USD | 206.686% |
| Evofem Biosciences, Inc. | 42.79 Million USD | 114.082% |
| Nascent Biotech, Inc. | -249.62 Thousand USD | -2314.069% |
| Rebus Holdings, Inc. | 305 Thousand USD | 2075.738% |
| Santhera Pharmaceuticals Holding AG | -6.3 Million USD | 4.418% |
| Qrons Inc. | 351.42 Thousand USD | 1814.723% |
| Adynxx, Inc. | - USD | Infinity% |
| Neon Bloom, Inc. | 622.36 Thousand USD | 1068.244% |
| Northwest Biotherapeutics, Inc. | 43.43 Million USD | 113.874% |
| ProtoKinetix, Incorporated | -20.4 Thousand USD | -29427.636% |
| Skye Bioscience, Inc. | -5.72 Million USD | -5.324% |
| Eiger BioPharmaceuticals, Inc. | 15.76 Million USD | 138.229% |
| Nanobac Pharmaceuticals, Incorporated | 4.11 Million USD | 246.332% |
| Institute of Biomedical Research Corp. | 401.84 Thousand USD | 1599.568% |
| SQZ Biotechnologies Company | -36.23 Million USD | 83.371% |
| Intellipharmaceutics International Inc. | 2.24 Million USD | 368.75% |
| Propanc Biopharma, Inc. | 927.18 Thousand USD | 749.924% |
| Mesoblast Limited | 55.85 Million USD | 110.788% |
| Marizyme, Inc. | 18.56 Million USD | 132.452% |
| Genus plc | 190.6 Million USD | 103.162% |
| VioQuest Pharmaceuticals, Inc. | 2.23 Million USD | 369.519% |
| Pharming Group N.V. | 109.8 Million USD | 105.488% |
| Therapeutic Solutions International, Inc. | 860.24 Thousand USD | 800.501% |
| CNBX Pharmaceuticals Inc. | 1.21 Million USD | 596.421% |
| Nymox Pharmaceutical Corporation | 680 Thousand USD | 986.176% |
| PsyBio Therapeutics Corp. | 134.63 Thousand USD | 4575.672% |
| Sienna Biopharmaceuticals, Inc. | - USD | Infinity% |
| RegeneRx Biopharmaceuticals, Inc. | 1.15 Million USD | 621.538% |
| IMV Inc. | 7.67 Million USD | 178.561% |
| AXIM Biotechnologies, Inc. | 5.5 Million USD | 209.526% |
| MultiCell Technologies, Inc. | 90.04 USD | 6692681.075% |
| ONE Bio Corp. | 9.04 Million USD | 166.659% |
| Accustem Sciences Inc. | -733.97 Thousand USD | -721.006% |
| RVL Pharmaceuticals plc | 12.94 Million USD | 146.547% |
| Arno Therapeutics, Inc. | - USD | Infinity% |
| EV Biologics, Inc. | 1.36 Million USD | 540.506% |
| Q BioMed Inc. | 4.06 Million USD | 248.423% |
| Emmaus Life Sciences, Inc. | 30.55 Million USD | 119.722% |
| Mosaic ImmunoEngineering Inc. | 1 Million USD | 697.986% |
| Biomind Labs Inc. | 711.4 Thousand USD | 947.06% |
| American Oriental Bioengineering, Inc. | 60.54 Million USD | 109.953% |
| Provectus Biopharmaceuticals, Inc. | 1.99 Million USD | 401.392% |
| TetraLogic Pharmaceuticals Corporation | - USD | Infinity% |
| Oncotelic Therapeutics, Inc. | 12.8 Million USD | 147.054% |
| GlobeStar Therapeutics Corporation | 359.71 Thousand USD | 1775.238% |
| THC Farmaceuticals, Inc. | 139.8 Thousand USD | 4410.32% |
| Acro Biomedical Co., Ltd. | 19.86 Thousand USD | 30431.706% |
| Curative Biotechnology, Inc. | 2.2 Million USD | 373.663% |
| GB Sciences, Inc. | 1.74 Million USD | 444.872% |
| Alpha Cognition Inc. | -183.78 Thousand USD | -3178.778% |
| HST Global, Inc. | 96.79 Thousand USD | 6325.657% |
| CSL Limited | 10.52 Billion USD | 100.057% |
| Wesana Health Holdings Inc. | 206.21 Thousand USD | 3022.165% |
| Halberd Corporation | 144.72 Thousand USD | 4263.874% |
| Enzolytics Inc. | 981.65 Thousand USD | 713.861% |
| Agentix Corp. | 37.63 Thousand USD | 16113.393% |
| Resverlogix Corp. | 6.45 Million USD | 193.412% |
| Nuo Therapeutics, Inc. | -673.08 Thousand USD | -795.275% |
| MetaStat, Inc. | - USD | Infinity% |
| argenx SE | -2.02 Billion USD | 99.703% |
| Enzon Pharmaceuticals, Inc. | -47.01 Million USD | 87.182% |
| Endonovo Therapeutics, Inc. | 7.07 Million USD | 185.222% |
| RespireRx Pharmaceuticals Inc. | 2.7 Million USD | 322.475% |
| GeneThera, Inc. | - USD | Infinity% |
| Inhibitor Therapeutics, Inc. | -8.83 Million USD | 31.832% |
| AVAX Technologies, Inc. | -5.9 Million USD | -2.08% |
| Zenith Capital Corp. | 10.06 Thousand USD | 59976.789% |
| Genscript Biotech Corporation | -1.06 Billion USD | 99.432% |
| Ember Therapeutics, Inc. | 200.43 Thousand USD | 3106.506% |
| Anthera Pharmaceuticals, Inc. | - USD | Infinity% |
| Sigyn Therapeutics, Inc. | 2.38 Million USD | 352.553% |
| WPD Pharmaceuticals Inc. | 164.5 Thousand USD | 3763.021% |
| Cotinga Pharmaceuticals Inc. | -18.31 Thousand USD | -32796.604% |
| Kadimastem Ltd | -253.1 Thousand USD | -2280.858% |
| Helix BioMedix, Inc. | -2.57 Million USD | -134.472% |
| VitaSpring Biomedical Co. Ltd. | - USD | Infinity% |
| Capstone Therapeutics Corp. | 20.27 Million USD | 129.72% |
| BioStem Technologies, Inc. | 4.47 Million USD | 234.749% |
| Oncology Pharma Inc. | - USD | Infinity% |
| Reve Technologies, Inc. | 201.25 Thousand USD | 3094.226% |
| LadRx Corporation | -2.03 Million USD | -195.904% |
| Cell Source, Inc. | 9.23 Million USD | 165.273% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 1048.727% |
| Regen BioPharma, Inc. | 635.16 Thousand USD | 1048.727% |
| NovAccess Global Inc. | 2.17 Million USD | 376.617% |
| Affymax, Inc. | -5.59 Million USD | -7.665% |
| Itoco Inc. | 228.3 Thousand USD | 2739.452% |
| Rasna Therapeutics, Inc. | 135.98 Thousand USD | 4531.241% |
| Pathfinder Cell Therapy, Inc. | 4.95 Million USD | 221.565% |
| Mobile Lads Corp. | 484.23 Thousand USD | 1344.445% |
| CytoDyn Inc. | 20.26 Million USD | 129.74% |
| Claritas Pharmaceuticals, Inc. | - USD | Infinity% |
| NDT Pharmaceuticals Inc. | -647.00 USD | -931275.58% |
| NanoSphere Health Sciences Inc. | -9268.34 USD | -64917.036% |
| Alseres Pharmaceuticals, Inc. | 7.7 Million USD | 178.199% |
| SYBLEU INC | 473.71 Thousand USD | 1372.076% |
| Advanced Proteome Therapeutics Corporation | - USD | Infinity% |
| ImmunoCellular Therapeutics, Ltd. | 4.45 Million USD | 235.202% |
| International Stem Cell Corporation | 2.59 Million USD | 332.664% |
| Bioxytran, Inc. | 1.89 Million USD | 417.339% |
| GlobeImmune, Inc. | - USD | Infinity% |
| Predictive Technology Group, Inc. | - USD | Infinity% |
| ProText Mobility, Inc. | 62.41 Thousand USD | 9755.04% |
| Cardax, Inc. | - USD | Infinity% |
| VG Life Sciences Inc. | 2.18 Million USD | 376.308% |
| Kaleido Biosciences, Inc. | - USD | Infinity% |
| Advaxis, Inc. | 3.43 Million USD | 275.48% |
| Adhera Therapeutics, Inc. | 8.55 Million USD | 170.455% |
| RenovaCare, Inc. | - USD | Infinity% |
| Regnum Corp. | 772.6 Thousand USD | 879.957% |
| Innovation Pharmaceuticals Inc. | -1.25 Million USD | -382.08% |
| Neutra Corp. | 52.18 Thousand USD | 11646.937% |
| Windtree Therapeutics, Inc. | -2.48 Million USD | -142.105% |
| PureTech Health plc | -167.19 Million USD | 96.396% |
| Coeptis Therapeutics, Inc. | -244.9 Thousand USD | -2360.516% |
| IXICO plc | -4.44 Million USD | -35.581% |
| IntelGenx Technologies Corp. | 13.21 Million USD | 145.586% |
| Gelesis Holdings, Inc. | 54.85 Million USD | 110.986% |
| CSL Limited | 10.52 Billion USD | 100.057% |
| Cellectis S.A. | -43.81 Million USD | 86.248% |